|
Schizophrenia Study Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Schizophrenia Study conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Schizophrenia Study Clinical research trials and Schizophrenia Study medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Schizophrenia Study. Schizophrenia Study Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Schizophrenia Study clinical trial. Participants frequently get the best healthcare available for their Schizophrenia Study condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Schizophrenia Study Schizophrenia Study
Schizophrenia Study
For Condition: Schizophrenia
Status: Completed
Sponsor(s): Sponsor Name Pending ,
Synopsis: A Placebo Controlled Study For Patients With Schizophrenia
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: (Patients must meet this criteria in order to be eligible for this study.) - Patient must meet diagnostic criteria for schizophrenia. Exclusion Criteria: (Patients cannot meet these criteria in order to be eligible for this study.) - Patients with other psychotic disorders. - Patients whose condition is due to the direct physiological effects of a substances (e.g., drug abuse) or a general medical condition. - Patients with a history of autistic disorder or another pervasive developmental disorder. - Patients with epilepsy or a history of seizures requiring treatment. - Patients who are excluded from taking the drug risperidone. - Patients who pose a current serious suicidal or homicidal risk. - Patients who are adequately stabilized on their treatment.
Total Enrollment:
Location and Contact Information:
Study Site
Pico Rivera, California, 90660
United States
Study Site
San Diego, California, 92126
United States
Study Site
Scottsdale, Arizona, 85251
United States
Study Site
Terrell, Texas, 75160
United States
Study Site
New Britain, Connecticut, 06050
United States
Study Site
Butner, North Carolina, 27509
United States
Study Site
Tampa, Florida, 33613
United States
Study Site
Norman, Oklahoma, 73069
United States
Study Site
Washington D.C., District of Columbia, 20016
United States
Study Site
Holliswood, New York, 11423
United States
Study Site
Winter Park, Florida, 32789
United States
Study Site
Sacramento, California, 95823
United States
Study Site
Austin, Texas, 78729
United States
Study Site
New Haven, Connecticut, 06519
United States
Study Site
San Diego, California, 92123
United States
Study Site
Greenwood, Indiana, 46143
United States
Study Site
Bellaire, Texas, 77401
United States
Study Site
Baltimore, Maryland, 21202
United States
Study Site
Shreveport, Louisiana, 71101
United States
Study Site
Clementon, New Jersey, 08021
United States
Study Site
Nashville, Tennessee, 37212
United States
Study Site
Rosemead, California, 91770
United States
Study Site
Hoffman Estates, Illinois, 60194
United States
Study Site
Orange, California, 92868
United States
Study Site
Miami, Florida, 33161
United States
Study Site
Cincinnati, Ohio, 45267
United States
Study Site
Cerritos, California, 90703
United States
Study Site
Miami, Florida, 33161
United States
Study Site
Garden Grove, California, 92845
United States
Study Site
Cleveland, Ohio, 44109
United States
Study Site
Oklahoma City, Oklahoma, 73103
United States
Study Site
Chapel Hill, North Carolina, 27599
United States
Additional Information:
Study ID Numbers: SB223412/078;
Study Start Date:
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00049946
Other Schizophrenia Studies:
1. Neuropsychological Evaluation of Psychiatric and Neurological Patients
2. CATIE- Schizophrenia Trial
3. Treatment of Childhood Onset Psychiatric Disorders with Intravenous Immunoglobulin (IVIg)
4. Imaging of Brain Receptors in Healthy Volunteers and in Patients with Schizophrenia
5. Rehabilitative Training for Older People with Schizophrenia
Related Studies:
Other Schizophrenia Clinical Trials
Other Connecticut Clinical Trials
Other New Haven Clinical Trials
Schizophrenia Study
|
|
|
|
|
|
|
|